Biobehavioral Intervention for Testicular Cancer
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Research shows that GET can help young adult testicular cancer survivors by reducing stress-related markers in the body and improving emotional regulation and goal-setting skills, which are important for managing the psychological impact of cancer.
12345GET has been studied in young adult testicular cancer survivors and showed potential to reduce stress-related processes and inflammation without significant adverse effects reported. More research is needed to confirm its safety and effectiveness.
12345Goal-Focused Emotion-Regulation Therapy (GET) is unique because it specifically targets the emotional and goal-related challenges faced by young adult testicular cancer survivors, aiming to improve distress symptoms and emotion regulation while also addressing stress-sensitive biomarkers, which is not commonly the focus of other treatments for this condition.
12346Eligibility Criteria
This trial is for young adults aged 18-39 who have had testicular cancer and finished chemotherapy within the last 4 years. They must be fluent in English or Spanish, feel distressed (scoring >4 on a Distress Thermometer), and be able to consent. It's not for regular smokers, those with immune-affecting conditions, recent heart attacks or strokes, Type I diabetes, acute hepatitis, recent vaccinations, or a history of psychiatric or cognitive disturbances.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive six sessions of Goal-focused Emotion-Regulation Therapy (GET) or Individual Supportive Listening (ISL) over eight weeks
Follow-up
Participants are monitored for psychological and biobehavioral outcomes post-treatment